Daniel A. Goldstein

7.3k total citations
175 papers, 5.0k citations indexed

About

Daniel A. Goldstein is a scholar working on Oncology, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel A. Goldstein has authored 175 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Oncology, 50 papers in Economics and Econometrics and 38 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel A. Goldstein's work include Economic and Financial Impacts of Cancer (42 papers), Health Systems, Economic Evaluations, Quality of Life (28 papers) and Cancer Immunotherapy and Biomarkers (24 papers). Daniel A. Goldstein is often cited by papers focused on Economic and Financial Impacts of Cancer (42 papers), Health Systems, Economic Evaluations, Quality of Life (28 papers) and Cancer Immunotherapy and Biomarkers (24 papers). Daniel A. Goldstein collaborates with scholars based in United States, Israel and Canada. Daniel A. Goldstein's co-authors include C. S. Patlak, Joseph F. Hoffman, Christopher R. Flowers, Mark J. Ratain, Moshe Leshno, Qiushi Chen, Noa Gordon, D. C. Hellam, Bassel F. El‐Rayes and W. H. Freygang and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Daniel A. Goldstein

170 papers receiving 4.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Daniel A. Goldstein 1.6k 920 810 677 424 175 5.0k
Michael D. Wiese 1.0k 0.6× 752 0.8× 422 0.5× 782 1.2× 368 0.9× 200 5.2k
Eva Ardanáz 1.7k 1.0× 579 0.6× 798 1.0× 248 0.4× 639 1.5× 142 5.2k
Judith S. Jacobson 4.2k 2.6× 582 0.6× 1.5k 1.8× 534 0.8× 995 2.3× 192 8.8k
Kotaro Ozasa 943 0.6× 839 0.9× 1.4k 1.8× 128 0.2× 692 1.6× 211 7.7k
Kenneth C. Chu 2.4k 1.5× 1.3k 1.5× 866 1.1× 173 0.3× 365 0.9× 98 5.9k
María‐José Sánchez 1.4k 0.8× 799 0.9× 552 0.7× 179 0.3× 505 1.2× 256 5.9k
Min Dai 1.5k 0.9× 1.2k 1.3× 634 0.8× 161 0.2× 928 2.2× 220 5.0k
Eric J. Duell 1.3k 0.8× 2.8k 3.1× 319 0.4× 198 0.3× 452 1.1× 120 6.8k
Hongxia Liu 824 0.5× 1.4k 1.5× 883 1.1× 129 0.2× 379 0.9× 84 7.6k
Ru Chen 2.2k 1.4× 1.6k 1.7× 1.3k 1.6× 187 0.3× 1.0k 2.4× 148 6.0k

Countries citing papers authored by Daniel A. Goldstein

Since Specialization
Citations

This map shows the geographic impact of Daniel A. Goldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Goldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Goldstein more than expected).

Fields of papers citing papers by Daniel A. Goldstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel A. Goldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Goldstein. The network helps show where Daniel A. Goldstein may publish in the future.

Co-authorship network of co-authors of Daniel A. Goldstein

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel A. Goldstein. A scholar is included among the top collaborators of Daniel A. Goldstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel A. Goldstein. Daniel A. Goldstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meirson, Tomer, Jonathan Ofer, Avital Bareket‐Samish, et al.. (2025). Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials With Differential Censoring. JAMA Network Open. 8(1). e2455630–e2455630. 1 indexed citations
2.
Goldstein, Daniel A., et al.. (2024). MAX phases: Unexpected reactivity under impact. Applied Materials Today. 40. 102389–102389.
3.
Tschernichovsky, Roi, Daniel A. Goldstein, Elizabeth Dudnik, et al.. (2023). Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non‐small cell lung cancer: A large real‐world cohort and review of the literature. Thoracic Cancer. 14(17). 1589–1596. 3 indexed citations
4.
Goldstein, Daniel A., Dionisia Quiroga, Mahmoud Kassem, et al.. (2023). The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer. Oncology and Therapy. 11(3). 361–374. 1 indexed citations
5.
Leader, Avi, Erez Batat, Tzippy Shochat, et al.. (2023). Arterial and Venous Thromboembolism in ALK-Rearrangement-Positive Non-small Cell Lung Cancer: A Population-Based Cohort Study. The Oncologist. 28(6). e391–e396. 4 indexed citations
6.
Peer, Cody J., Keith T. Schmidt, Oluwatobi Arisa, et al.. (2023). In Silico Re‐Optimization of Atezolizumab Dosing Using Population Pharmacokinetic Simulation and Exposure–Response Simulation. The Journal of Clinical Pharmacology. 63(6). 672–680. 9 indexed citations
7.
Tannock, Ian F., Daniel A. Goldstein, Jonathan Ofer, Bishal Gyawali, & Tomer Meirson. (2023). Evaluating Trials of Adjuvant Therapy: Is There Benefit for People With Resected Renal Cancer?. Journal of Clinical Oncology. 41(15). 2713–2717. 10 indexed citations
8.
Strohbehn, Garth W., Alec Kacew, Daniel A. Goldstein, Robin Feldman, & Mark J. Ratain. (2021). Combination therapy patents: a new front in evergreening. Nature Biotechnology. 39(12). 1504–1510. 9 indexed citations
9.
Briggs, Andrew, Daniel A. Goldstein, Rachel Meacock, et al.. (2020). Estimating (quality‐adjusted) life‐year losses associated with deaths: With application to COVID‐19. Health Economics. 30(3). 699–707. 43 indexed citations
10.
Moore, Assaf, et al.. (2020). Potential Association between Kaposi Sarcoma and Gout: An Exploratory Observational Study. Sarcoma. 2020. 1–5. 1 indexed citations
11.
Goldstein, Daniel A., Tzippy Shochat, Assaf Moore, et al.. (2020). The concordance of treatment decision guided by OncotypeDX and the PREDICT tool in real‐world early‐stage breast cancer. Cancer Medicine. 9(13). 4603–4612. 4 indexed citations
12.
McGuire, Shelley, Shelley McGuire, William J. Price, et al.. (2016). Glyphosate and aminomethylphosphonic acid are not detectable in human milk. American Journal of Clinical Nutrition. 103(5). 1285–1290. 57 indexed citations
13.
Davis, Christine, et al.. (2016). Clinical Utility of Routine Cardiac Monitoring in Breast Cancer Patients Receiving Trastuzumab. Annals of Pharmacotherapy. 50(9). 712–717. 11 indexed citations
14.
Burns, Carol J., J. Michael Wright, Jennifer Pierson, et al.. (2014). Evaluating Uncertainty to Strengthen Epidemiologic Data for Use in Human Health Risk Assessments. Environmental Health Perspectives. 122(11). 1160–1165. 30 indexed citations
15.
Morris, Patrick G., Xi Kathy Zhou, Ginger L. Milne, et al.. (2013). Increased Levels of Urinary PGE-M, a Biomarker of Inflammation, Occur in Association with Obesity, Aging, and Lung Metastases in Patients with Breast Cancer. Cancer Prevention Research. 6(5). 428–436. 57 indexed citations
16.
Burns, Carol J. & Daniel A. Goldstein. (2005). Pesticides and Neurologic Symptoms. Environmental Health Perspectives. 113(12). A800–A800. 1 indexed citations
17.
Bishop, James F., Joanna Dewar, Guy C. Toner, et al.. (1997). A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer : Preliminary results. Seminars in Oncology. 24(5). 6 indexed citations
18.
Nolten, Wolfram E., Daniel A. Goldstein, Mary J. Lindstrom, et al.. (1993). Effects of Cytokines on the Pituitary–Adrenal Axis in Cancer Patients. Journal of Interferon Research. 13(5). 349–357. 42 indexed citations
19.
Witt, Patricia L., Daniel A. Goldstein, Barry E. Storer, et al.. (1992). Absence of Biological Effects of Orally Administered Interferon-β ser. Journal of Interferon Research. 12(6). 411–413. 36 indexed citations
20.
Freygang, W. H., Daniel A. Goldstein, D. C. Hellam, & Lee D. Peachey. (1964). The Relation Between the Late After-Potential and the Size of the Transverse Tubular System of Frog Muscle. The Journal of General Physiology. 48(2). 235–263. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael D. Wiese Breakdown of academic impact, for papers by Eva Ardanáz Breakdown of academic impact, for papers by Judith S. Jacobson Breakdown of academic impact, for papers by Kotaro Ozasa Breakdown of academic impact, for papers by Kenneth C. Chu Breakdown of academic impact, for papers by María‐José Sánchez Breakdown of academic impact, for papers by Min Dai Breakdown of academic impact, for papers by Eric J. Duell Breakdown of academic impact, for papers by Hongxia Liu Breakdown of academic impact, for papers by Ru Chen
Rankless by CCL
2026